Analysis of Scoliosis Management Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Worldwide revenue from the global scoliosis management market is estimated to reach US$ 3.05 billion in 2024. The market is analyzed to climb to a value of US$ 4.39 billion by the end of 2034, expanding at a CAGR of 3.7% over the next ten years.
Scoliosis is characterized by abnormal sideways curvature of the spine. While a slight curvature is normal, a more pronounced curve in the shape of an S or C is associated with scoliosis. Although the exact cause of scoliosis is not known, factors such as genetics, neuromuscular disorders, and congenital abnormalities of the spine are known to be risk factors.
While the disease affects both sexes equally, the progression of the curve in females is eight times faster than in males. Nevertheless, the patient must wear the device for 22 to 23 hours every day, which stiffens their body and causes skin irritation and rashes. In addition, it causes breathing difficulties and presses against the chest wall and abdomen, which may impair pulmonary and oxygen flow.
Key Market Growth Drivers
| Report Attribute | Detail |
|---|---|
| Scoliosis Management Market Size (2024E) | US$ 3.05 Billion |
| Forecasted Market Value (2034F) | US$ 4.39 Billion |
| Global Market Growth Rate (2024 to 2034) | 3.7% CAGR |
| Latin America Market Share (2024E) | 8.3% |
| North America Market Share (2024E) | 39.5% |
| Revenue from Online Sales (2024E) | US$ 1.22 Billion |
| Key Companies Profiled | DJO Global; TRULIFE; Wellinks, Inc.; Horton’s Orthotics & Prosthetics; Boston O&P; Bauerfeind AG; Spinal Technology Inc.; GE Healthcare; Zimmer Biomet; Medtronic; Exponent Inc. |
“Government Initiatives and Funding for Scoliosis Research and Treatment Development”
Juvenile scoliosis is diagnosed between the ages of 5 and 9 years. Scoliosis tends to grow faster at this age, meaning that it is becoming progressive and does not go away on its own. Young people with scoliosis typically experience a right bend. Since scoliosis advances with age, patients receiving brace treatment have their spines strengthened and the condition's progressiveness is halted. A child's growth necessitates changing the braces every 12 to 18 months due to varying degrees of curvature, which is driving market growth.
High prevalence of the condition, developments in cutting-edge technologies, government support, and growing demand for non-invasive surgical therapies are contributing to scoliosis management market growth.
“High Cost of Therapy and Less Awareness about Scoliosis”
Insufficient awareness about scoliosis, its signs, and available treatments are limiting the growth of the market. There is a lack of awareness about the illness among a large number of people, including patients, caregivers, and even medical professionals, which could cause delays in the diagnosis and start of treatment.
Scoliosis sometimes goes undetected or is mistakenly diagnosed as a benign postural problem because it develops gradually and can first manifest as subtle symptoms such as uneven hips or shoulders. As a result, individuals might require quicker medical attention. Demand for scoliosis management is being restricted by a lack of skilled healthcare providers, unfavorable payment policies, and a lack of awareness about the condition and treatment options.
There is a high demand for diagnosis and treatment options in North America due to the rising prevalence of scoliosis among the population, especially among teenagers.
“Well-established Healthcare System and High Prevalence of Scoliosis”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 979 Million |
| Growth Rate (2024 to 2034) | 3% CAGR |
| Projected Value (2034F) | US$ 1.31 Billion |
The United States is estimated to hold 81.2% of the scoliosis management market share in North America in 2024. The country’s well-established healthcare system is expected to drive significant revenue growth for the market.
“Increased Adoption of Orthopedic Implants Essential to Scoliosis Management”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 198 Million |
| Growth Rate (2024 to 2034) | 3.6% CAGR |
| Projected Value (2034F) | US$ 282 Million |
Brazil is estimated to account for 78.2% market share in Latin America in 2024. The increased incidence of scoliosis in Brazil is fueling the need for management strategies. The adoption of orthopedic implant adoption is gaining traction, which is fueling market expansion. These implants are essential to the management of scoliosis. The market is further stimulated by an increasing number of scoliosis surgeries.
The thoracolumbosacral orthosis (TLSO) product segment is projected to expand at a steady rate over the projection period. Based on age group, the market is segmented into three segments: infantile, adolescent, and young adult. Adolescents are set to account for 72% of the global market share in 2024.
“Role of TLSO Management in Protecting Lower Thoracic Spine”
| Attribute | Thoracolumbosacral Orthosis |
|---|---|
| Segment Value (2024E) | US$ 2.48 Billion |
| Growth Rate (2024 to 2034) | 3.8% CAGR |
| Projected Value (2034F) | US$ 3.6 Billion |
The thoracolumbosacral orthosis (TLSO) sub-segment is expected to hold 81.3% market share in terms of value in 2024. The lower thoracic spine is suitably protected by a well-built TLSO. An intact rib cage reduces fracture displacement and offers relative stability in the upper thoracic spine.
It is hard to immobilize this section of the spine with straightforward orthoses. Despite frequent attempts, effective immobilization of the lumbar spine-particularly its lower segment and the lumbosacral junction-is challenging to accomplish through orthotic means. To attain optimal external immobilization for the lowest spine regions, it is necessary to use a hip spica or a rigid pelvic girdle.
“e-Commerce Platforms Facilitating Informed Decision-making for Equipment Purchases”
| Attribute | Online Sales |
|---|---|
| Segment Value (2024E) | US$ 1.22 Billion |
| Growth Rate (2024 to 2034) | 3.8% CAGR |
| Projected Value (2034F) | US$ 1.77 Billion |
The online channel is set to hold 40% of the market share in 2024. Pharmaceutical vendors provide patients and healthcare providers with a quick and easy way to find and buy the tools they require by integrating e-commerce platforms. This implies that patients can buy and receive their prescription medications from the convenience of their own homes in a business-to-consumer setting.
Comprehensive pharmaceutical e-commerce platforms, when used in a business-to-business setting, can enable suppliers to make educated drug purchases by comparing and contrasting all of the various, ever-changing factors involved in drug purchases, such as the prices and availability of various drugs at any given time.
Key players in the scoliosis management market are investing in research & development to expand and enhance their product offerings. Mergers and acquisitions and collaborations with other organizations are examples of significant market developments. Producing affordable goods is essential for the scoliosis treatment industry to grow in an increasingly competitive and expanding market.
To improve their position in markets across the globe, a sizable portion of businesses involved in the global scoliosis management market are focusing their efforts on establishing alliances and partnerships with local distributors and retailers.
Fact.MR provides detailed information about the price points of key providers of scoliosis management solutions positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
How big is the global scoliosis management market?
The global market for scoliosis management is expected to be valued at US$ 3.05 billion in 2024.
What are the sales projections for scoliosis management over the decade?
The global market is forecasted to expand at 3.7% CAGR and reach US$ 4.39 billion by the end of 2034.
Which country has a significant market for scoliosis management?
Revenue from scoliosis management in the United States is projected to reach US$ 979 million in 2024.
What are the projections for the market in Brazil?
Brazil is estimated to reach a market value of US$ 198 million in 2024.
Which distribution channel accounts for higher sales of scoliosis management solutions?
Revenue from online sales is estimated to reach US$ 1.22 billion in 2024.
What is the market share of Canada in North America?
Canada accounts for a market share of 15.7% in North America in 2024.
Who are the leaders in the business of scoliosis management?
Spinal Technology Inc., GE Healthcare, Zimmer Biomet, Medtronic, and Exponent Inc. are some of the key players in the market.
Scoliosis Management Market